UTRECHT, The Netherlands and CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a...
Related Keywords
Cambridge , Cambridgeshire , United Kingdom , Netherlands , , Exchange Commission , Molecular Targets , New Therapies , Private Securities Litigation Reform Act , Quarterly Report , Nasdaq Mrus , Merusnv , Serus ,
comparemela.com © 2020. All Rights Reserved.